Net Income

With 1,600 exhibitors and a 'Smart Revolution' theme, interzum guangzhou 2026 is set to redefine the global furniture industry with AI and sustainability.

UK biotech Amphista to showcase its innovative Targeted Glue™ platform at AACR, revealing new data for AML, lung cancer, and mesothelioma therapies.

The Dutch public sector bank saw a €122M profit drop in 2025, a deliberate move to fund vital social projects and accelerate green initiatives.

Futurionex and MicAi-X claim their new automated trading system reduces risk, but can algorithms truly bring stability to the volatile crypto market?

The food-tech firm boosts its shareholder dividend, signaling financial health, yet its stock trades near a 52-week low. What's behind the disconnect?

The company's first full year in logistics shows massive revenue growth, yet widening losses and an asset write-down raise questions about its path forward.

A new AI platform from TRACE ASI promises powerful market insights for all, but can it truly level the playing field in an already crowded tech market?

A lack of transparency in the critical first and last mile of freight is costing businesses billions. As e-commerce soars, can technology fix the chaos?

The AI safety firm has begun generating revenue from its first contracts, opened a Nashville office, and initiated plans for a major stock exchange uplisting.

Texas's largest agricultural lender distributes over $100 million in cash to its members, reinforcing the power of its cooperative business model.

Texas LNG's decision to build key components in-state aims to sidestep global risks, create hundreds of local jobs, and redefine cleaner energy exports.

Savaria’s consistent dividend signals robust financial health, tapping into a growing market driven by powerful demographic shifts and the 'aging in place' trend.

Richtech Robotics hires top-tier auditor CBIZ, citing a strategic shift, but SEC filings reveal a prior warning about a “material weakness” in controls.

Apple iSports hires innovation guru Ian Wilding to guide its Nasdaq ambitions, a move underscored by a corrective press release signaling growing pains.

RenovoRx sets a key update call, juggling early RenovoCath device sales with its pivotal Phase III pancreatic cancer trial, a beacon for patients.

China Natural Resources, with a tiny $5M market cap, plans to buy a majority stake in AI startup HooRii for $40M, a high-risk pivot for survival.

A brain aneurysm device successful in Europe has treated its first U.S. patient in a pivotal trial, promising to expand treatment options for thousands.

OEM demand for certified, integrated security is reshaping the semiconductor market, driving M&A and a race to develop quantum-resistant technology.

A new development in Miami Gardens partners Italian luxury design with advanced tech, promising equitable housing. But can it deliver on its lofty goals?

Egide Group centralizes its US manufacturing in Maryland, closing its California site in a strategic move to boost efficiency and sharpen its competitive edge.